UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
The Samsung Group has admitted that a Samsung-affiliated company failed to ...
by Jeong Sae-im
|
2019-10-16 14:16
라인
Eulji Medical Center transfers advanced medical expertise to Bangladesh
Eulji Medical Center (EMC) said Wednesday that it would provide invitation ...
by Lee Han-soo
|
2019-10-16 11:28
라인
Seoul Medical Center transfer public healthcare know-how to developing countries
Seoul Medical Center (SMC) is speeding up the transfer of "Seoul-model publ...
by Lee Han-soo
|
2019-10-15 18:02
라인
‘Genome analysis-based therapy to help realize precision medicine’
Samsung Medical Center has become the world’s first hospital to demonstrate...
by Lee Han-soo
|
2019-10-15 17:50
라인
'High ozone levels can aggravate dry eye symptoms'
A research team at Gacheon University Gil Medical Center has found that hig...
by Lee Han-soo
|
2019-10-15 17:50
라인
Merck Korea forcefully shuts down general medicine biz
Merck Biopharma Korea said it would complete shutting down the General Medi...
by Kim Yun-mi
|
2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration
Galderma recently debuted as the world’s largest independent dermatology co...
by Kim Yun-mi
|
2019-10-15 13:56
라인
Korea brings up Fukushima’s radioactive water disposal issue at WHO
The Ministry of Health and Welfare said that it conveyed the Korean governm...
by Lee Han-soo
|
2019-10-15 12:54
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal
Medytox and Daewoong Pharmaceutical continued to brawl over the origin of t...
by Lee Han-soo
|
2019-10-15 11:28
라인
Kolon Life Science shares surge after TissueGene’s survival
Shares of Kolon Life Science shot up after the regulator decided to delay t...
by Jeong Sae-im
|
2019-10-14 18:01
라인
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
The Korean branch of Eli Lilly said it has presented the phase 4 IXORA-R st...
by Lee Han-soo
|
2019-10-14 18:01
라인
First lung disease reported here with suspected ties to vaping
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo
|
2019-10-14 18:01
라인
HLB merges with Elevar to own rivoceranib rights
HLB said it would merge with its subsidiary Elevar, a U.S.-based developer ...
by Jeong Sae-im
|
2019-10-14 14:43
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment
HanAll Biopharma said that Harbour Biomed, its Chinese partner, has complet...
by Lee Han-soo
|
2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi
|
2019-10-14 13:45
라인
Sanofi releases data showing improved survival for prostate cancer treatment
Sanofi said that it has published research results confirming a longer radi...
by Lee Han-soo
|
2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
The Korean Exchange (KRX) decided to keep Kolon Tissuegene listed on the Ko...
by Lee Han-soo
|
2019-10-12 09:41
라인
GC to market Merck's diabetes treatment
Merck Biopharma Korea said that GC would market Glucophage, its diabetes tr...
by Lee Han-soo
|
2019-10-11 18:13
라인
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo
|
2019-10-11 16:36
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon
|
2019-10-11 16:35
-
이전
91
92
93
94
95
96
97
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top